Search
中/EN
Contact/Message
Home
central pharmacy
Policies
Medical Institution
Franchise
Innovate
Recruit
News
Search
Home
central pharmacy
Policies
Medical Institution
Franchise
Innovate
Recruit
News
中/EN
Contact/Message
Innovate
Your current position:
Home
Innovate
International innovative drugs
DOLUTEGRAVIR;EMTRICITABINE;TENOFOVIR ALAFENAMIDE
DOLUTEGRAVIR;EMTRICITABINE;TENOFOVIR ALAFENAMIDE
departments:
感染科
drug:
片剂
Active:
DOLUTEGRAVIR;EMTRICITABINE;TENOFOVIR ALAFENAMIDE
indication:
艾滋病
Licensor:
Laurus Generics, Inc.
Approved Country/Region:
美国
Approval time:
2023-10-12